FDA Inspection 1096138 — Ann C. Henderson Tilton, M.D.
The FDA completed an inspection of Ann C. Henderson Tilton, M.D. on June 26, 2019 in New Orleans, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 26, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Orleans, LA (United States)
Additional Details
Clinical Investigator (CI)